Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Abstract Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tole...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Malaria Journal |
Online Access: | http://link.springer.com/article/10.1186/s12936-019-2955-z |